Cardiome Pharma Corp. Announces Appointment of Jennifer Archibald as Chief Financial Officer

Published: Sep 21, 2012

VANCOUVER, British Columbia, Sept. 20, 2012 (GLOBE NEWSWIRE) -- Cardiome Pharma Corp. (Nasdaq:CRME) (TSX:COM) is pleased to announce the appointment of Jennifer Archibald as Chief Financial Officer (CFO) of the company, following the resignation of Curtis Sikorsky. Mr. Sikorsky will continue to serve the company in a consulting capacity to assist during the transition.

Back to news